Navigating Access and Reimbursement Through Uncertainty
Pharmaceutical Commerce
JANUARY 3, 2025
A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.
Fri.Jan 03, 2025
59 
IIT Guwahati and Bose Institute develop injectable hydrogel for cancer
Pharmaceutical Technology
JANUARY 3, 2025
The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Brain study challenges long-held views about Parkinson's movement disorders
Medical Xpress
JANUARY 3, 2025
University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of treatment.
Expanding diagnostic and biomarker options to improve MASH clinical trials
Pharmaceutical Technology
JANUARY 3, 2025
Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA approves Sequana Medical’s Alfapump for ascites treatment
Pharma Times
JANUARY 3, 2025
FDA gives green light to innovative device for liver conditions
SIGA’s antiviral approved in Japan for orthopoxvirus treatment
Pharmaceutical Technology
JANUARY 3, 2025
SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
From Davids to Goliaths: the GLP-1R gold rush
Pharmaceutical Technology
JANUARY 3, 2025
There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
Capricor files cell therapy for DMD cardiomyopathy with FDA
pharmaphorum
JANUARY 3, 2025
Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
Pharmaceutical Technology
JANUARY 3, 2025
China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination
AI system helps doctors identify patients at risk for suicide
Medical Xpress
JANUARY 3, 2025
A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts in routine medical settings.
NHS Confederation welcomes social care commission announcement
Pharma Times
JANUARY 3, 2025
Government announces independent commission on social care
Scientists unveil surprising human vs. mouse differences in a major cancer immunotherapy target
Medical Xpress
JANUARY 3, 2025
Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer treatments. A checkpoint receptor that often resides on the surface of immune system cells, the PD-1 molecule works as a type of "off" switch that keeps immune cells from attacking other cells.
Regeneron builds in eye disease tech with Oxular takeover
pharmaphorum
JANUARY 3, 2025
Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.
Modeling tool estimates COVID-19 testing saved 1.4 million lives
Medical Xpress
JANUARY 3, 2025
The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the Johns Hopkins Applied Physics Laboratory (APL) and a team of collaborators underscores that principle.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Patient organisations 'too influenced by corporate funders'
pharmaphorum
JANUARY 3, 2025
Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.
How a simple amino acid could shape immune response
Medical Xpress
JANUARY 3, 2025
A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.
Tryngolza (Olezarsen) Becomes First FDA-Approved Drug for Familial Chylomicronemia Syndrome
XTalks
JANUARY 3, 2025
For the first time in the US, adults living with familial chylomicronemia syndrome (FCS) have an FDA-approved treatment option. Ionis Pharmaceuticals recently announced that its drug, Tryngolza (olezarsen), has been approved as an adjunct to diet for the reduction of triglyceride levels in FCS patients, who have long faced a condition with no existing pharmacological solutions.
New study highlights need for clearer medical reports to ease patient worry
Medical Xpress
JANUARY 3, 2025
In April 2021, a provision in the 21st Century Cures act took effect which required that all medical test results be released to a patient's electronic medical record as soon as they become available. As a result of this newer law, many patients are seeing and reading their test results even before their doctor has.
Pharma Pulse 1/3/25: Navigating Fertility Misinformation on Social Media, Nearly 75% of Adolescents Experience Depression/Anxiety & more
Pharmaceutical Commerce
JANUARY 3, 2025
The latest news for pharma industry insiders.
Study shows 'good' cholesterol may protect against brain atrophy, dementia
Medical Xpress
JANUARY 3, 2025
High-density lipoprotein (HDL), or "good" cholesterol, may play a vital role in conserving healthy brain matter in middle-aged adults, UT Southwestern Medical Center researchers report. The findings, published in the Journal of Clinical Medicine, could give doctors and patients more insight into factors that affect cognitive health in aging adults.
Seeing is investing: The power of visuals at every stage of development
pharmaphorum
JANUARY 3, 2025
As biotech start-ups evolve, the ability to communicate effectively with key stakeholders those who will fund the next stage of your journey becomes crucial.
Novel class of anti-malaria antibodies could lead to next-generation interventions
Medical Xpress
JANUARY 3, 2025
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study by researchers at the National Institutes of Health (NIH) published today in Science.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Peer Exchange: The Future of RFID and Supply Chain Management (Episode 6)
Pharmaceutical Commerce
JANUARY 3, 2025
In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.
Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases
Medical Xpress
JANUARY 3, 2025
A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.
A five-step approach for optimising established brands' portfolio value
pharmaphorum
JANUARY 3, 2025
A five-step approach for optimising established brands' portfolio value Nicole.
Improving predictions about brain cancer outcomes with the right imaging criteria
Medical Xpress
JANUARY 3, 2025
A paper published in the Journal of Clinical Oncology, titled "Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204," examines how different imaging criteria can be used to assess brain tumor responses in patients with melanoma treated with immunotherapy drugs.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
London-listed Poolbeg discussing Hookipa merger
pharmaphorum
JANUARY 3, 2025
The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.
Tinnitus risk increased for patients with gastroesophageal reflux disease
Medical Xpress
JANUARY 3, 2025
Patients with gastroesophageal reflux disease (GERD) have an increased risk for tinnitus, according to a study published online Dec. 3 in Scientific Reports.
[ELLIS] Study day 'monitoring and mitigating environmental health inequalities'
Sciensano
JANUARY 3, 2025
Event type: conference Audience: general public health professionals journalist PhD students policy makers representatives of care and professional organisations scientists university staff Description: We are happy to invite you to the final event of the Belspo-funded ELLIS project aiming to develop policy-relevant tools to monitor and mitigate environmental health inequalities in Belgium.
Peer pressure still influences older adult alcohol consumption, says study
Medical Xpress
JANUARY 3, 2025
Think you're too old to cave to peer pressure when it comes to boozing?
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content